Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Valérie Cartron"'
Autor:
Arnaud Pillon, Bruno Gomes, Isabelle Vandenberghe, Valérie Cartron, Patrick Cèbe, Jean-Christophe Blanchet, Vincent Sibaud, Nicolas Guilbaud, Laurent Audoly, Laurence Lamant, Anna Kruczynski
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179991 (2017)
Actinic keratoses (AK) are pre-malignant cutaneous lesions caused by prolonged exposure to ultraviolet radiation. As AKs lesions are generally accepted to be the initial lesions in a disease continuum that progresses to squamous cell carcinoma (SCC),
Externí odkaz:
https://doaj.org/article/9a3be95c1fc441a59b977904332b2515
Autor:
Maxime Lafond, Fabrice Prieur, Cyril Lafon, Valérie Cartron, Nathalie Chansard, Arnaud Pillon, Patrick Cèbe, Jean-Louis Mestas
Publikováno v:
Ultrasound in medicinebiology. 42(7)
Ultrasound-induced cavitation has found many applications in the field of cancer therapy. One of its beneficial effects is the enhancement of drug intake by tumor cells. Our group has developed a device that can create and control unseeded cavitation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79de64bf950f2a48cada6958251a99c0
https://pubmed.ncbi.nlm.nih.gov/27087691
https://pubmed.ncbi.nlm.nih.gov/27087691
Autor:
Vanessa Offrete, Nathalie Chansard, Laurent Créancier, Jean-Christophe Blanchet, Jérôme Verdier, Jean-Philippe Annereau, Anna Kruczynski, Stéphane Gras, Christian Bailly, Arnaud Pillon, Bruno Gomes, Emmanuel Fournier, Viviane Brel, Sandrine Pourtau, Sabine Roy, Caroline Dejean, Nicolas Guilbaud, Karine Andre, Yves Guminski, Valérie Cartron, Christel Ricome, Isabelle Vandenberghe-Huez
Publikováno v:
Cancer Research. 72:2747-2747
New antileukemic agents are urgently needed to achieve improvement of the survival of patients suffering from Acute Myelogenous Leukemia (AML). F14512 combines an epipodophyllotoxin core with a spermine moiety that targets cells with a high demand fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b702a150b1cf50d575301ab5f7e0da1
https://doi.org/10.1158/1538-7445.am2012-2747
https://doi.org/10.1158/1538-7445.am2012-2747
Autor:
Eric Delabesse, Anna Kruczynski, Yves Guminski, Jean-Emmanuel Sarry, Laurent Créancier, Nicolas Guilbaud, Sandrine Pourtau, Jérôme Verdier, Arnaud Pillon, Jean-Philippe Annereau, Bruno Gomes, Valérie Cartron, Cécile Demur, Christel Ricome, Stéphane Gras, Fabien Marty, Christian Recher, Emmanuel Fournier, Vanessa Offrete, Nathalie Chansard, Jean-Christophe Blanchet, Isabelle Vandenberghe, Christian Bailly, Sabine Roy
Publikováno v:
Molecular Cancer Therapeutics. 10:A214-A214
Chemotherapy remains mainly used for the treatment of Acute Myelogenous Leukemia (AML). However, in the past 3 decades limited progress has been achieved in improving the long-term disease-free survival. Therefore the development of more effective dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6be833fd54b5ab35c0dc2004abb12e5f
https://doi.org/10.1158/1535-7163.targ-11-a214
https://doi.org/10.1158/1535-7163.targ-11-a214
Autor:
Anna Kruczynski, Nathalie Chansard, Christian Bailly, Sabrina Pesnel, Thierry Imbert, Nathalie Gallay, Cécile Demur, Yoann Menon, Laurent Créancier, Isabelle Vandenberghe, Christel Ricome, Bruno Gomes, Fabien Marty, Nicolas Guilbaud, Bernard Payrastre, Yves Guminski, Arnaud Pillon, Valérie Cartron, Sandrine Pourtau, Jean-Christophe Blanchet, Alain Le Pape, Christian Recher
Publikováno v:
Molecular Cancer Therapeutics. 8:B186-B186
Despite advances in the therapy of acute myeloid leukemia (AML), the majority of patients die from their disease. Therefore, the lack of effective therapy mandates the development of novel compounds to improve the outcome of patients with relapsed an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c55aea2e65062b6c0b26b1337a0ce41
https://doi.org/10.1158/1535-7163.targ-09-b186
https://doi.org/10.1158/1535-7163.targ-09-b186